Regeneron Pharmaceuticals (REGN) had the highest return since April 30, 1992 and in February 2000 by a US stock in the S&P 500 (GSPC), returning 369.6%.
| ASSET | % RETURN |
|---|---|
Regeneron Pharmaceuticals (REGN) | 369.61% |
Incyte (INCY) | 152.52% |
IDEXX Laboratories (IDXX) | 92.45% |
Adobe Systems (ADBE) | 82.55% |
NetApp (NTAP) | 81.27% |
Vertex Pharmaceuticals (VRTX) | 77.95% |
ResMed (RMD) | 74.56% |
Skyworks Solutions (SWKS) | 73.88% |
NVIDIA (NVDA) | 72.36% |
Analog Devices (ADI) | 69.09% |
Gilead Sciences (GILD) | 64.95% |
Agilent Technologies (A) | 56.79% |
VeriSign (VRSN) | 55.75% |
Micron Technology (MU) | 54.53% |
Texas Instruments (TXN) | 54.36% |
Microchip Technology (MCHP) | 50.6% |
Autodesk (ADSK) | 48.03% |
Oracle (ORCL) | 44.88% |
Genesis Healthcare (GEN) | 40.42% |
Henry Schein (HSIC) | 39.53% |
PTC (PTC) | 39.37% |
Bio-Techne (TECH) | 37.94% |
Cognizant Technology Solutions Corp Class A (CTSH) | 37.47% |
Applied Materials (AMAT) | 36.78% |
Teradyne (TER) | 34.36% |
